In-Stent Atherosclerosis at a Crossroads
Author:
Affiliation:
1. From Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA (I.A., P.H.S.); and Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge (I.A.).
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Link
https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.116.025129
Reference5 articles.
1. Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment
2. Mechanisms of Very Late Drug-Eluting Stent Thrombosis Assessed by Optical Coherence Tomography
3. Neoatherosclerosis After Paclitaxel-Coated Balloon Angioplasty for In-Stent Restenosis
4. Atherosclerotic plaque behind the stent changes after bare-metal and drug-eluting stent implantation in humans: Implications for late stent failure?
5. Incidence and Clinical Significance of Poststent Optical Coherence Tomography Findings
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. “Spongy skin” as a robust strategy to deliver 4-octyl itaconate for conducting dual-regulation against in-stent restenosis;Biomaterials;2023-05
2. Ginsenoside Rh1 protects human endothelial cells against lipopolysaccharide-induced inflammatory injury through inhibiting TLR2/4-mediated STAT3, NF-κB, and ER stress signaling pathways;Life Sciences;2022-11
3. Mid-Term Clinical Outcomes Following Drug-Coated Balloons in Coronary Artery Disease;Journal of Clinical Medicine;2022-03-27
4. miR-22 eluting cardiovascular stent based on a self-healable spongy coating inhibits in-stent restenosis;Bioactive Materials;2021-12
5. Procedural Results and Long-Term Outcomes of Percutaneous Coronary Intervention for in-Stent Restenosis Chronic Total Occlusion Compared with de novo Chronic Total Occlusion;International Journal of General Medicine;2021-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3